These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8000861)

  • 1. Aminotransferase catalysis applied to the synthesis of a PAF antagonist.
    Coffen DL; Okabe M; Sun RC; Lee S; Matcham GW
    Bioorg Med Chem; 1994 Jun; 2(6):411-3. PubMed ID: 8000861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentadienyl carboxamide derivatives as antagonists of platelet-activating factor.
    Guthrie RW; Kaplan GL; Mennona FA; Tilley JW; Kierstead RW; Mullin JG; LeMahieu RA; Zawoiski S; O'Donnell M; Crowley H
    J Med Chem; 1989 Aug; 32(8):1820-35. PubMed ID: 2754709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propenyl carboxamide derivatives as antagonists of platelet activating factor.
    Guthrie RW; Kaplan GL; Mennona FA; Tilley JW; Kierstead RW; O'Donnell M; Crowley H; Yaremko B; Welton AF
    J Med Chem; 1990 Oct; 33(10):2856-64. PubMed ID: 2170651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial/enzymatic synthesis of chiral drug intermediates.
    Patel RN
    Adv Appl Microbiol; 2000; 47():33-78. PubMed ID: 12876794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The design of novel N-4'-pyridinyl-alpha-methyl proline derivatives as potent catalysts for the kinetic resolution of alcohols.
    Priem G; Pelotier B; Macdonald SJ; Anson MS; Campbell IB
    J Org Chem; 2003 May; 68(10):3844-8. PubMed ID: 12737562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and structure-activity relationship studies of novel 1-[(1-acyl-4-piperidyl)methyl]-1H-2- methylimidazo[4,5-c]pyridine derivatives as potent, orally active platelet-activating factor antagonists.
    Carceller E; Merlos M; Giral M; Balsa D; García-Rafanell J; Forn J
    J Med Chem; 1996 Jan; 39(2):487-93. PubMed ID: 8558517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]52770 RP, a platelet-activating factor receptor antagonist, and tritiated platelet-activating factor label a common specific binding site in human polymorphonuclear leukocytes.
    Marquis O; Robaut C; Cavero I
    J Pharmacol Exp Ther; 1988 Feb; 244(2):709-15. PubMed ID: 2831350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic racemization of amines catalyzed by enantiocomplementary ω-transaminases.
    Koszelewski D; Grischek B; Glueck SM; Kroutil W; Faber K
    Chemistry; 2011 Jan; 17(1):378-83. PubMed ID: 21207634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel azo derivatives as prodrugs of 5-aminosalicylic acid and amino derivatives with potent platelet activating factor antagonist activity.
    Carceller E; Salas J; Merlos M; Giral M; Ferrando R; Escamilla I; Ramis J; García-Rafanell J; Forn J
    J Med Chem; 2001 Aug; 44(18):3001-13. PubMed ID: 11520209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel antagonists of platelet-activating factor. 1. Synthesis and structure-activity relationships of benzodiazepine and benzazepine derivatives of 2-methyl-1-phenylimidazo[4,5-c]pyridine.
    Fray MJ; Cooper K; Parry MJ; Richardson K; Steele J
    J Med Chem; 1995 Sep; 38(18):3514-23. PubMed ID: 7658438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-transaminases as efficient biocatalysts to obtain novel chiral selenium-amine ligands for Pd-catalysis.
    Andrade LH; Silva AV; Milani P; Koszelewski D; Kroutil W
    Org Biomol Chem; 2010 May; 8(9):2043-51. PubMed ID: 20401380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of (R)- or (S)-valinol using ω-transaminases in aqueous and organic media.
    Fuchs CS; Simon RC; Riethorst W; Zepeck F; Kroutil W
    Bioorg Med Chem; 2014 Oct; 22(20):5558-62. PubMed ID: 24951100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-(3-Pyridyl)thiazolidine-4-carboxamide derivatives. II. Structure-activity relationships and active configuration of 2-(3-pyridyl)thiazolidine-4-carboxamides as platelet-activating factor receptor antagonists.
    Suzuki T; Nagaoka H; Kondo Y; Takahashi T; Takeuchi M; Hara H; Saito M; Yamada T; Tomioka K; Hamada M; Mase T
    Chem Pharm Bull (Tokyo); 1998 Sep; 46(9):1468-73. PubMed ID: 9775441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel antagonists of platelet-activating factor. 2. Synthesis and structure-activity relationships of potent and long-acting heterofused [1,5]benzodiazepine and [1,4]diazepine derivatives of 2-methyl-1-phenylimidazo[4,5-c]pyridine.
    Fray MJ; Bull DJ; Cooper K; Parry MJ; Stefaniak MH
    J Med Chem; 1995 Sep; 38(18):3524-35. PubMed ID: 7658439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New total synthesis and high resolution 1H NMR spectrum of platelet-activating factor, its enantiomer and racemic mixtures.
    Heymans F; Michel E; Borrel MC; Wichrowski B; Godfroid JJ; Convert O; Coeffier E; Tence M; Benveniste J
    Biochim Biophys Acta; 1981 Nov; 666(2):230-7. PubMed ID: 7306563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships in platelet-activating factor (PAF antagonists). 6. Synthesis and in vitro antagonistic activities of 2-substituted 5-oxotetrahydrofurans.
    Favre E; Heymans F; Redeuilh C; Batt JP; Massicot F; Blavet N; Braquet P; Godfroid JJ
    J Lipid Mediat; 1992 Feb; 5(1):23-40. PubMed ID: 1449553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activating factor as a proinflammatory mediator in acetic-induced colitis in the rat.
    Will PC; Thomas TK; Iverson L; Buckman D; Weis W; Wilson C; Srivastava A
    Agents Actions; 1991 Sep; 34(1-2):181-4. PubMed ID: 1793026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships of kadsurenone analogues.
    Ponpipom MM; Bugianesi RL; Brooker DR; Yue BZ; Hwang SB; Shen TY
    J Med Chem; 1987 Jan; 30(1):136-42. PubMed ID: 3027330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonists.
    Curtin ML; Davidsen SK; Heyman HR; Garland RB; Sheppard GS; Florjancic AS; Xu L; Carrera GM; Steinman DH; Trautmann JA; Albert DH; Magoc TJ; Tapang P; Rhein DA; Conway RG; Luo G; Denissen JF; Marsh KC; Morgan DW; Summers JB
    J Med Chem; 1998 Jan; 41(1):74-95. PubMed ID: 9438024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An efficient enantioselective synthesis of (S)-(-)-acromelobic acid.
    Adamczyk M; Akireddy SR; Reddy RE
    Org Lett; 2000 Nov; 2(22):3421-3. PubMed ID: 11081998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.